Adherence to treatment in inflammatory bowel disease
Aim: adherence to therapy is important to ensure success. We wanted to explore this feature in patients with inflammatory bowel disease. Patients and methods: we explored adherence to treatment and its modifiers in 40 patients with inflammatory bowel disease using a battery of tests. Results: a 67% of patients (95% CI: 51-81%) acknowledged a certain degree of involuntary nonadherence, and 35% (95% CI: 20-51%) of voluntary nonadherence. Overall, 72% (95% CI: 56-85%) of patients had some form of nonadherence. An objective correlation of these self-reported data was assessed by the determination of urine salicylate levels in the subset of patients treated with mesalazine or its derivatives (15 cases). Two of them (13%) had no detectable urinary drug levels, indicating complete nonadherence. Voluntary nonadherence was higher in patients with lower scores in the intestinal (p = 0.02) and social areas (p = 0.015) of IBDQ-32, as well as in those with less active Crohn's disease (p < 0.005), patients with high depression scores and high patient-physician discordance (p = 0.01), patients with long-standing disease (p = 0.057), patients who considered themselves not to be well informed about the treatment they were getting (p = 0.04) or who trusted their attending physicians less (p = 0.03). Conclusions: intentional nonadherence to therapy is prevalent among patients with inflammatory bowel disease. A correction of factors associated to poor adherence could lead to higher therapeutic success.
Main Authors: | López San Román,A., Bermejo,F., Carrera,E., Pérez-Abad,M., Boixeda,D. |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedad Española de Patología Digestiva
2005
|
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082005000400005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: Calvo-Arbeloa,María, et al.
Published: (2020) -
Inflammatory bowel disease in Spain: problems grow
by: López San Román,A., et al.
Published: (2004) -
The complexity of evaluating and increasing adherence in inflammatory bowel disease
by: Weimers,Petra, et al.
Published: (2017) -
Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid
by: López-Serrano,P., et al.
Published: (2009) -
Nutritional treatment in inflammatory bowel disease: An update
by: Guagnozzi,Danila, et al.
Published: (2012)